NO20074362L - Farmasoytisk preparat inneholdende magnetiske vesikulaere partikler, fremgangsmate for fremstilling av disse, og diagnostisk terapeutisk system - Google Patents

Farmasoytisk preparat inneholdende magnetiske vesikulaere partikler, fremgangsmate for fremstilling av disse, og diagnostisk terapeutisk system

Info

Publication number
NO20074362L
NO20074362L NO20074362A NO20074362A NO20074362L NO 20074362 L NO20074362 L NO 20074362L NO 20074362 A NO20074362 A NO 20074362A NO 20074362 A NO20074362 A NO 20074362A NO 20074362 L NO20074362 L NO 20074362L
Authority
NO
Norway
Prior art keywords
particles
magnetic
vesicular particles
containing magnetic
vesicular
Prior art date
Application number
NO20074362A
Other languages
English (en)
Norwegian (no)
Inventor
Toshihisa Takeyama
Original Assignee
Konica Minolta Med & Graphic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Konica Minolta Med & Graphic filed Critical Konica Minolta Med & Graphic
Publication of NO20074362L publication Critical patent/NO20074362L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/183—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an inorganic material or being composed of an inorganic material entrapping the MRI-active nucleus, e.g. silica core doped with a MRI-active nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/225—Microparticles, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20074362A 2005-01-28 2007-08-27 Farmasoytisk preparat inneholdende magnetiske vesikulaere partikler, fremgangsmate for fremstilling av disse, og diagnostisk terapeutisk system NO20074362L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005021899 2005-01-28
PCT/JP2006/300813 WO2006080243A1 (fr) 2005-01-28 2006-01-20 Particule magnetique enrobee contenant une preparation, un procede de production de celle-ci et un systeme therapeutique de diagnostic

Publications (1)

Publication Number Publication Date
NO20074362L true NO20074362L (no) 2007-10-02

Family

ID=36740276

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074362A NO20074362L (no) 2005-01-28 2007-08-27 Farmasoytisk preparat inneholdende magnetiske vesikulaere partikler, fremgangsmate for fremstilling av disse, og diagnostisk terapeutisk system

Country Status (6)

Country Link
US (1) US20060171894A1 (fr)
EP (1) EP1842554A1 (fr)
JP (1) JPWO2006080243A1 (fr)
AU (1) AU2006209654A1 (fr)
NO (1) NO20074362L (fr)
WO (1) WO2006080243A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004112747A2 (fr) 2003-06-24 2004-12-29 Baxter International Inc. Methode d'administration de medicaments au cerveau
US8986736B2 (en) 2003-06-24 2015-03-24 Baxter International Inc. Method for delivering particulate drugs to tissues
US20060239925A1 (en) * 2005-04-21 2006-10-26 Konica Minolta Medical & Graphic, Inc. Method of manufacturing pharmaceutical preparation containing liposomes
JP5364876B2 (ja) * 2006-04-03 2013-12-11 国立大学法人東京工業大学 ウイルス粒子様構造体およびそれを含有する製剤
EP2088926A4 (fr) * 2006-11-02 2011-07-13 Immunivest Corp Imagerie d'endothélium vasculaire activé au moyen d'agents de contraste immunomagnétiques pour irm
JP5142251B2 (ja) * 2007-04-20 2013-02-13 国立大学法人大阪大学 金酸化鉄粒子を利用した複合粒子およびｍｒｉ造影剤
ES2320837B1 (es) * 2007-07-26 2010-03-04 Consejo Superior De Investigaciones Cientificas Dispositivo de hipertermia y su utilizacion con nanoparticulas.
JP2009051752A (ja) * 2007-08-24 2009-03-12 Hitachi Ltd 磁性粒子含有薬剤キャリア及びそれを用いた治療装置
EP2259798B1 (fr) 2008-03-05 2013-12-11 Baxter International Inc. Compositions et procédés d administration de médicament
GB0811856D0 (en) 2008-06-27 2008-07-30 Ucl Business Plc Magnetic microbubbles, methods of preparing them and their uses
US10952965B2 (en) 2009-05-15 2021-03-23 Baxter International Inc. Compositions and methods for drug delivery
JP2012081125A (ja) * 2010-10-13 2012-04-26 Gunze Ltd 陰圧治療装置及びその制御方法
JP6297440B2 (ja) * 2013-07-31 2018-03-20 キヤノンメディカルシステムズ株式会社 造影剤
US10561745B2 (en) * 2017-03-28 2020-02-18 The Florida International University Board Of Trustees Stimuli-responsive magneto-plasmonic nanocarrier

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466609A (en) * 1990-10-31 1995-11-14 Coulter Corporation Biodegradable gelatin-aminodextran particle coatings of and processes for making same
WO1993026019A1 (fr) * 1992-06-08 1993-12-23 Molecular Bioquest, Inc. Preparation de particules inorganiques a dimensions reglables utiles dans des separations, comme commutateurs moleculaires magnetiques et comme liposomes inorganiques dans des applications medicales
JPH09110722A (ja) * 1995-10-20 1997-04-28 Toray Ind Inc 抗腫瘍活性物質の腫瘍細胞内導入用イムノリポソーム及びその調製法
US6493570B1 (en) * 1998-11-02 2002-12-10 Photogen, Inc. Method for improved imaging and photodynamic therapy
US6997863B2 (en) * 2001-07-25 2006-02-14 Triton Biosystems, Inc. Thermotherapy via targeted delivery of nanoscale magnetic particles
WO2004083124A1 (fr) * 2003-03-17 2004-09-30 Kansai Technology Licensing Organization Co. Ltd. Particule composite d'oxyde metallique magnetique-metal noble et procede pour la produire
JP2005010590A (ja) * 2003-06-20 2005-01-13 Fuji Xerox Co Ltd 画像形成装置及び画像形成方法
US8067176B2 (en) * 2008-01-25 2011-11-29 Shimadzu Corporation Microchemistry reaction method

Also Published As

Publication number Publication date
AU2006209654A1 (en) 2006-08-03
WO2006080243A1 (fr) 2006-08-03
EP1842554A1 (fr) 2007-10-10
JPWO2006080243A1 (ja) 2008-06-19
US20060171894A1 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
NO20074362L (no) Farmasoytisk preparat inneholdende magnetiske vesikulaere partikler, fremgangsmate for fremstilling av disse, og diagnostisk terapeutisk system
Shi et al. Toward drug release using polymer mechanochemical disulfide scission
Yan et al. Activating antitumor immunity and antimetastatic effect through polydopamine‐encapsulated core–shell upconversion nanoparticles
Pu et al. Sono‐controllable and ROS‐sensitive CRISPR‐Cas9 genome editing for augmented/synergistic ultrasound tumor nanotherapy
Chang et al. Colorectal tumor microenvironment‐activated bio‐decomposable and metabolizable Cu2O@ CaCO3 nanocomposites for synergistic oncotherapy
Zeng et al. Activatable cancer sono‐immunotherapy using semiconducting polymer nanobodies
Yang et al. [Gd@ C82 (OH) 22] n nanoparticles induce dendritic cell maturation and activate Th1 immune responses
Kager et al. Review of mifamurtide in the treatment of patients with osteosarcoma
Yang et al. Preparation of folic acid-conjugated, doxorubicin-loaded, magnetic bovine serum albumin nanospheres and their antitumor effects in vitro and in vivo
Tang et al. Preparation and biodistribution of 188Re-labeled folate conjugated human serum albumin magnetic cisplatin nanoparticles (188Re-folate-CDDP/HSA MNPs) in vivo
Yue et al. Melanin-like nanomedicine in photothermal therapy applications
Guo et al. Smart 131I‐Labeled Self‐Illuminating Photosensitizers for Deep Tumor Therapy
JPH02502015A (ja) 細胞毒性薬との組合せにおける血管収縮性物質
Sun et al. Nanoengineered neutrophils as a cellular sonosensitizer for visual sonodynamic therapy of malignant tumors
Huang et al. Self-driven nanoprodrug platform with enhanced ferroptosis for synergistic photothermal-IDO immunotherapy
Chen et al. Dual drugs decorated bacteria irradiate deep hypoxic tumor and arouse strong immune responses
Zhao et al. Engineering nano–bio interfaces from nanomaterials to nanomedicines
JP2009500441A5 (fr)
Li et al. Metal-phenolic networks with ferroptosis to deliver NIR-responsive CO for synergistic therapy
Mirjolet et al. Docetaxel-titanate nanotubes enhance radiosensitivity in an androgen-independent prostate cancer model
CN105641710B (zh) Ha/rgd修饰的靶向氧化石墨烯双载药复合材料制备方法
Kim et al. Injectable hydrogel-based combination cancer immunotherapy for overcoming localized therapeutic efficacy
Zhu et al. Recent advances of nanotechnology-facilitated bacteria-based drug and gene delivery systems for cancer treatment
Shen et al. TAM-targeted reeducation for enhanced cancer immunotherapy: Mechanism and recent progress
Li et al. NIR-responsive hollow germanium nanospheres mediate photothermal/photodynamic therapy and restrain immunosuppression to cooperatively eradicate primary and metastatic tumors

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application